Home/Filings/4/0001654954-24-007464
4//SEC Filing

Maggiore Christopher D. 4

Accession 0001654954-24-007464

CIK 0001101026other

Filed

Jun 5, 8:00 PM ET

Accepted

Jun 6, 6:30 PM ET

Size

17.4 KB

Accession

0001654954-24-007464

Insider Transaction Report

Form 4
Period: 2024-06-05
Transactions
  • Disposition to Issuer

    Nonstatutory Stock Option to Purchase Common Stock

    2024-06-057070 total
    Exercise: $17.16Exp: 2032-12-15Common Stock (707 underlying)
  • Disposition to Issuer

    Nonstatutory Stock Option to Purchase Common Stock

    2024-06-057,0000 total
    Exercise: $33.00Exp: 2031-10-20Common Stock (7,000 underlying)
  • Disposition to Issuer

    Nonstatutory Stock Option to Purchase Common Stock

    2024-06-052,6320 total
    Exercise: $21.66Exp: 2032-07-27Common Stock (2,632 underlying)
  • Award

    Common Stock

    2024-06-05+36,630373,446 total
  • Award

    Common Stock

    2024-06-05$7.96/sh+81,544$649,090454,990 total
  • Disposition to Issuer

    Nonstatutory Stock Option to Purchase Common Stock

    2024-06-051,9020 total
    Exercise: $26.88Exp: 2031-10-11Common Stock (1,902 underlying)
  • Disposition to Issuer

    Nonstatutory Stock Option to Purchase Common Stock

    2024-06-053,6260 total
    Exercise: $16.74Exp: 2033-06-11Common Stock (3,626 underlying)
Footnotes (4)
  • [F1]The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023.
  • [F2]The canceled options were fully vested.
  • [F3]The Issuer canceled options for an aggregate 15,867 shares of the Issuer's common stock granted to the Reporting Person on 10/12/2021, 10/21/2021, 7/28/2022, 12/16/2022, and 6/12/2023. In exchange for the canceled options, the Reporting Person received 36,630 shares of restricted stock.
  • [F4]The canceled option was issued pursuant to the 2021 Equity Incentive Plan on 6/12/2023 and vests as follows: 25% on the first three 3-month anniversaries of the grant, and 25% on the day prior to the Company's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service on each applicable vesting date.

Issuer

Zivo Bioscience, Inc.

CIK 0001101026

Entity typeother

Related Parties

1
  • filerCIK 0001436075

Filing Metadata

Form type
4
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 6:30 PM ET
Size
17.4 KB